Revolution Medicines (RVMD) return on invested capital (ROIC)

Return on invested capital · fiscal 2024
-487.5%

Revolution Medicines (RVMD) earned a return on invested capital of -487.5% in fiscal 2024 (the year ended December 31, 2024). That is 141.6 percentage points higher than the -629.1% of fiscal 2023. Figures as of 18 Nov 2026, 01:28 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on invested capital, fiscal 2024
-487.5%
Change on fiscal 2023
+141.6 pts
Highest on record
-195.3%fiscal 2022
Lowest on record
-629.1%fiscal 2023
Fiscal years on record
32022–2024

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Revolution Medicines return on invested capital (ROIC), in more detail

Across the 3 fiscal years on record (2022–2024), the highest was -195.3% in fiscal 2022 and the lowest -629.1% in fiscal 2023.

History · 3 fiscal years

Return on invested capital by fiscal year

Revolution Medicines return on invested capital (ROIC), year by year

Revolution Medicines (RVMD) return on invested capital (ROIC) by fiscal year
Fiscal yearReturn on invested capitalChangeYear ended
2024-487.5% 141.6 pts up
2023-629.1% 433.7 pts down
2022-195.3%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on invested capital is operating income after tax divided by the capital in the business — debt plus equity minus cash — using the company's own tax rate where it is plausible and 21% otherwise, and shown only for the fiscal years in which cash is counted one way.

How to read it

It measures how well the business turns capital into profit whoever supplied it; a figure above the cost of that capital, roughly 8–10%, means growth creates value.

Return on invested capital at health care companies of similar size

Return on invested capital of Revolution Medicines and comparable companies
CompanyReturn on invested capitalFiscal year
BeOne Medicines ONC34.0%2025
Waters WAT19.7%2025
Natera NTRA-28.8%2025
IQVIA Holdings IQV9.5%2025
Revolution Medicines RVMD-487.5%2024
Royalty Pharma RPRX8.8%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RVMD

Revolution Medicines, figure by figure

Revolution Medicines (RVMD) overview: price, valuation and scorecardAll health care companies by market value

Revolution Medicines return on invested capital (ROIC): questions and answers

What is Revolution Medicines's return on invested capital?

Revolution Medicines (RVMD) earned a return on invested capital of -487.5% in fiscal 2024 (the year ended December 31, 2024). That is 141.6 percentage points higher than the -629.1% of fiscal 2023.

What are the highest and lowest return on invested capital figures on record for Revolution Medicines?

Across the 3 fiscal years on record (2022–2024), the highest was -195.3% in fiscal 2022 and the lowest -629.1% in fiscal 2023.

How is Revolution Medicines's return on invested capital calculated?

Return on invested capital is operating income after tax divided by the capital in the business — debt plus equity minus cash — using the company's own tax rate where it is plausible and 21% otherwise, and shown only for the fiscal years in which cash is counted one way.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Revolution Medicines (RVMD) return on invested capital (ROIC)”, data as of 18 November 2026. https://funkfolio.com/stock/RVMD/roic

Underlying data: the company's filings with the SEC and Yahoo Finance.